BrainsWay Ltd. ( BWAY) - Key Metrics
BWAY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.49 | $0.09 | $0.02 | $0.05 |
| 2025Q3 | $0.36 | $0.04 | $0.04 | $0.02 |
| 2025Q2 | $0.31 | $0.05 | $0.31 | $0.28 |
| 2025Q1 | $0.31 | $0.03 | $0.14 | $0.11 |
| 2024Q4 | $0.33 | $0.04 | $0.10 | $0.07 |
BWAY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 26.27 |
| 2025Q3 | ? | 46.30 |
| 2025Q2 | ? | 32.95 |
| 2025Q1 | ? | 37.86 |
| 2024Q4 | ? | 25.72 |
BWAY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 0.30% | ? |
| 2025Q3 | 0.20% | ? |
| 2025Q2 | 4.51% | ? |
| 2025Q1 | 2.27% | ? |
| 2024Q4 | 1.45% | ? |
BWAY
Price: $14.06
52 week price:
Earnings Per Share: 0.22 USD
P/E Ratio: 67.64
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: Israel
Volume: 22800
Market Capitalization: 559.7 million